# YingTai(Suzhou) Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yingtai-suzhou-medical-technology-co

- Industry: Healthcare
- Headquarters: Shanghai, China
- Website: http://www.yingtaipro.com/en/index.html
- Total disclosed funding: $1.4M
- Latest round: Seed (Oct 19, 2022)
- Investors on record: 2

## About

YingTai(Suzhou) Medical Technology Co.,Ltd, based in China, specializes in the manufacturing of surgical packs and medical supplies, enhancing healthcare delivery through innovative solutions.Founded in 2017 and headquartered in Shanghai, China, YingTai(Suzhou) Medical Technology Co.,Ltd focuses on surgical pack manufacturing. The firm secured CNY 10 million in Seed funding on October 19, 2022, led by CD Capital and Langmafeng Venture Capital, marking its first investment round.YingTai(Suzhou) Medical Technology Co.,Ltd offers a variety of innovative surgical packs designed to meet specific challenges faced by healthcare providers. Their core offering includes a flagship product that enhances operational efficiency for medical professionals. The company also provides technical support and consultancy services to ensure clients maximize the benefits from their products, focusing on markets in North America and parts of Europe, serving hospitals and healthcare facilities.The company employs a subscription-based revenue model, allowing healthcare providers to access their surgical products through monthly or annual payments. Various tiered plans cater to different facility sizes, promoting long-term relationships through continuous support and updates. This structure ensures a steady revenue stream as the firm explores partnerships with distributors to penetrate new markets.YingTai(Suzhou) Medical Technology Co.,Ltd plans to utilize the CNY 10 million raised in Seed funding for continuous innovation, clinical studies, and the development of R&D and manufacturing facilities in Erjiata, focusing on pelvic floor and urogenital health products. The company aims for geographic expansion into international markets over the next few years, enhancing their product offerings and reach to better serve global healthcare needs.

## Funding rounds

- Seed, Oct 19, 2022, $1.4M — CD Capital, Langmafeng Venture Capital

## Investors

- CD Capital — Seed
- Langmafeng Venture Capital — Seed